Cargando…
Target selectivity in mRNA silencing
Despite the excitement and promise of RNA interference in treating neurodegenerative disease, disease gene mRNA might resist mRNA silencing. Conventional siRNA design does not uniformly distinguish a mutant from a wild-type allele. CAG expansions in trinucleotide repeat diseases are unselective targ...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091803/ https://www.ncbi.nlm.nih.gov/pubmed/16520821 http://dx.doi.org/10.1038/sj.gt.3302726 |
_version_ | 1783510063868018688 |
---|---|
author | Aronin, N |
author_facet | Aronin, N |
author_sort | Aronin, N |
collection | PubMed |
description | Despite the excitement and promise of RNA interference in treating neurodegenerative disease, disease gene mRNA might resist mRNA silencing. Conventional siRNA design does not uniformly distinguish a mutant from a wild-type allele. CAG expansions in trinucleotide repeat diseases are unselective targets for small siRNAs. This review will consider recent discoveries in mechanisms of RNA interference and siRNA modifications that improve siRNA selectivity, delivery and performance. |
format | Online Article Text |
id | pubmed-7091803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70918032020-03-24 Target selectivity in mRNA silencing Aronin, N Gene Ther Article Despite the excitement and promise of RNA interference in treating neurodegenerative disease, disease gene mRNA might resist mRNA silencing. Conventional siRNA design does not uniformly distinguish a mutant from a wild-type allele. CAG expansions in trinucleotide repeat diseases are unselective targets for small siRNAs. This review will consider recent discoveries in mechanisms of RNA interference and siRNA modifications that improve siRNA selectivity, delivery and performance. Nature Publishing Group UK 2006-02-16 2006 /pmc/articles/PMC7091803/ /pubmed/16520821 http://dx.doi.org/10.1038/sj.gt.3302726 Text en © Nature Publishing Group 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Aronin, N Target selectivity in mRNA silencing |
title | Target selectivity in mRNA silencing |
title_full | Target selectivity in mRNA silencing |
title_fullStr | Target selectivity in mRNA silencing |
title_full_unstemmed | Target selectivity in mRNA silencing |
title_short | Target selectivity in mRNA silencing |
title_sort | target selectivity in mrna silencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091803/ https://www.ncbi.nlm.nih.gov/pubmed/16520821 http://dx.doi.org/10.1038/sj.gt.3302726 |
work_keys_str_mv | AT aroninn targetselectivityinmrnasilencing |